In the current worldwide COVID-19 pandemic situation, fast developments not only in vaccines are needed, but also in analytical techniques to detect the infection, predict outcomes during hospitalization and more and more important towards Long COVID.
An international research network initiated by Bruker and under the guidance of the Australian National Phenome Center (ANPC) run by Prof. Jeremy Nicholson has been set up in April 2020. It is a worldwide international COVID Research Network consisting of several institutions which collaborate, using completely standardized NMR* procedures producing spectral data, exchangeable and integratable across the Network.
We interviewed them to find out about this new approach in science and get to know the latest findings in this interesting approach to tackle this topic together to find faster solutions than usual by sharing research findings.
*Bruker NMR Instruments are for research Use Only. Not for Use in Clinical Diagnostic Procedures
Interviews with the NMR* International COVID-19 Research Network members
Elaine Holmes
Head of the Centre for Computational & Systems Medicine Murdoch University Perth, Australia
Julien Wist
Prof. for Computational Spectroscopy, Deputy Director ANPC, Murdoch University, Australia
Tobias Madl
Assoc. Prof., Group Leader Integrated Structural Biology, Medical University of Graz, Austria
Ulrich Günther
Professor for Metabolomics at the Chemical Institute at University Lübeck, Germany
Oscar Millet
Principal Investigator, Group Leader CiC BioGune, Bilbao, Spain
Christoph Trautwein
Group Leader Metabolomics and Systems Medicine
University Hospital Tübingen, Germany
Tone Frost Bathen
Prof. MR technology, Head of NMR cancer Group NTNU, Norway
Markus Voehler
Research Assoc. Prof., Director Biomolecular NMR Facility, Vanderbilt University, USA
